- Email: [email protected]
X–Flow North America relocates to Rockford
Filtration Industry Analyst
NEWS
DONALDSON, PGI TEAM UP FOR EPA-STANDARD BAG MEDIA Donaldson Co Inc and Polymer Group Inc have entered a strategic relationship to produce industrial filter bag media that they say will transform the present standards in the baghouse industry. Donaldson Torit will incorporate PGI’s award-winning Durapex nonwoven fabrics for filtration media in its first fit and replacement baghouse product line. PGI designed Durapex specifically to meet the EPA’s National Ambient Air Quality Standard (NAAQS) that calls for a limit of 2.5 micrometres for particulate matter. “Teaming up with PGI enables us to deliver industrial air filtration solutions that offer superior value to our customers,” said Steve Groves, global product director, Donaldson Torit. “The new relationship with PGI will allow us to offer the most innovative technology in the baghouse industry in decades.” “We are thrilled to be working with Donaldson, the world leader in filtration, to bring their customers a valueadded alternative,” said Rick Pearce, PGI’s senior director of business marketing.
EFP, ITOCHU APPLY FOR JAPANESE APPROVAL Emergency Filtration Products Inc (EFP) is undertaking a feasibility study with Itochu Techno Chemical Inc, a wholly-owned Japanese subsidiary of Itochu Corp, with a view to introducing EFP’s innovative air filtration products and technologies into Japan and other Asian countries.
16
March 2004
The two companies have filed an application with the Japanese Koseisho, which is similar to the US Federal Drug Administration. Once Koseisho approval has been secured, Itochu Techno Chemical will start distributing EFP’s Vapor Isolation Valve and other designated products in Japan and other Asian countries, with possible expansion into global markets. “We are honored to be working with world class companies such as Itochu Techno Chemical and its partners, whose professionalism and dedication make us highly confident that our collaboration to distribute our products in Japan and other Asian countries will be highly successful,” said EFP president Douglas Beplate. “Further, we view this partnership as a seminal event in our corporate history, and expect significant growth in sales as a result of Itochu Techno Chemical’s commitment to our products.” EFP has been collaborating with Itochu Techno Chemical for nearly a year. The companies entered into a Memorandum of Understanding last September and are now in the final phase of concluding a long-term distribution agreement.
PENTAIR ESTIMATES A 30% GAIN IN Q1 2004 EPS Pentair expects first quarter 2004 earnings per share (EPS) to be US$0.70–0.75, which is approximately 30% higher than the US$0.56 delivered in the first quarter of 2003. This compares with analysts’ first quarter 2004 consensus earnings estimates of US$0.65. The company is anticipating continued organic growth and improved profit contributions from each of its three groups, driven by
ongoing benefits from its five operating initiatives and the integration of the recent Everpure acquisition (see FIA, December 2003). First quarter 2004 expected organic growth is approximately 6%, excluding the impact of a few extra days in the quarter and foreign exchange. This change in guidance is expected to translate into full-year 2004 EPS of US$3.25–3.35 compared with Pentair’s previous estimate of US$3.15–3.30. This excludes any potential impact from the planned acquisition of Wicor Industries (see FIA, February 2004).
X-FLOW NORTH AMERICA RELOCATES TO ROCKFORD X-Flow North America has completed its move to Rockford, Illinois, coordinating its activities with its Norit sister companies, Sudmo and Haffmans. The three divisions of Norit will share common resources in finance, administration, inside sales and inventory management at the Rockford location. Jack Jordan, president of Sudmo North America, will also manage the X-Flow North America (XNA) business. Louis LeBrun remains XNA’s technical manager, and the team has been strengthened with the addition of Chris Shea, as sales & marketing director, and Todd Broad, as process engineer. LeBrun has been with X-Flow since its introduction to the US market three years ago. Shea has worked in membrane sales and business development in the water, wastewater and battery separation industries with WR Grace, USFilter and Koch. Broad has been an engineer with Illinois Water Treatment, a division of USFilter, for the past 14 years.
Editorial Office Elsevier Advanced Technology PO Box 150 Kidlington Oxford OX5 1AS United Kingdom Tel: +44 (0)1865 843695 Fax: +44 (0)1865 843971 E-mail: [email protected] Web: www.filtsep.com Editor Roisin Reidy Permissions may be sought directly from Elsevier Rights & Permissions Department, PO Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, e-mail: [email protected]. You may also contact Rights & Permissions directly through Elsevier’s home page (http://www.elsevier.com), selecting first ‘Customer Support’, then ‘General Information’, then Permissions Query Form’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: (978) 7508400, fax: (978) 7504744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: (+44) (0)20 7436 5931 ; fax: (+44) (0)20 7631 5500. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the publisher is required for resale or distribution outside the institution. Permission of the publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Contact the publisher at the address indicated. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the publisher. Address permissions requests to: Elsevier Rights & Permissions Department, at the mail, fax and e-mail addresses noted above. Notice No responsibility is assumed by the publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
02207 Printed by Mayfield Press (Oxford) Limited, UK.
NEWS
DONALDSON, PGI TEAM UP FOR EPA-STANDARD BAG MEDIA Donaldson Co Inc and Polymer Group Inc have entered a strategic relationship to produce industrial filter bag media that they say will transform the present standards in the baghouse industry. Donaldson Torit will incorporate PGI’s award-winning Durapex nonwoven fabrics for filtration media in its first fit and replacement baghouse product line. PGI designed Durapex specifically to meet the EPA’s National Ambient Air Quality Standard (NAAQS) that calls for a limit of 2.5 micrometres for particulate matter. “Teaming up with PGI enables us to deliver industrial air filtration solutions that offer superior value to our customers,” said Steve Groves, global product director, Donaldson Torit. “The new relationship with PGI will allow us to offer the most innovative technology in the baghouse industry in decades.” “We are thrilled to be working with Donaldson, the world leader in filtration, to bring their customers a valueadded alternative,” said Rick Pearce, PGI’s senior director of business marketing.
EFP, ITOCHU APPLY FOR JAPANESE APPROVAL Emergency Filtration Products Inc (EFP) is undertaking a feasibility study with Itochu Techno Chemical Inc, a wholly-owned Japanese subsidiary of Itochu Corp, with a view to introducing EFP’s innovative air filtration products and technologies into Japan and other Asian countries.
16
March 2004
The two companies have filed an application with the Japanese Koseisho, which is similar to the US Federal Drug Administration. Once Koseisho approval has been secured, Itochu Techno Chemical will start distributing EFP’s Vapor Isolation Valve and other designated products in Japan and other Asian countries, with possible expansion into global markets. “We are honored to be working with world class companies such as Itochu Techno Chemical and its partners, whose professionalism and dedication make us highly confident that our collaboration to distribute our products in Japan and other Asian countries will be highly successful,” said EFP president Douglas Beplate. “Further, we view this partnership as a seminal event in our corporate history, and expect significant growth in sales as a result of Itochu Techno Chemical’s commitment to our products.” EFP has been collaborating with Itochu Techno Chemical for nearly a year. The companies entered into a Memorandum of Understanding last September and are now in the final phase of concluding a long-term distribution agreement.
PENTAIR ESTIMATES A 30% GAIN IN Q1 2004 EPS Pentair expects first quarter 2004 earnings per share (EPS) to be US$0.70–0.75, which is approximately 30% higher than the US$0.56 delivered in the first quarter of 2003. This compares with analysts’ first quarter 2004 consensus earnings estimates of US$0.65. The company is anticipating continued organic growth and improved profit contributions from each of its three groups, driven by
ongoing benefits from its five operating initiatives and the integration of the recent Everpure acquisition (see FIA, December 2003). First quarter 2004 expected organic growth is approximately 6%, excluding the impact of a few extra days in the quarter and foreign exchange. This change in guidance is expected to translate into full-year 2004 EPS of US$3.25–3.35 compared with Pentair’s previous estimate of US$3.15–3.30. This excludes any potential impact from the planned acquisition of Wicor Industries (see FIA, February 2004).
X-FLOW NORTH AMERICA RELOCATES TO ROCKFORD X-Flow North America has completed its move to Rockford, Illinois, coordinating its activities with its Norit sister companies, Sudmo and Haffmans. The three divisions of Norit will share common resources in finance, administration, inside sales and inventory management at the Rockford location. Jack Jordan, president of Sudmo North America, will also manage the X-Flow North America (XNA) business. Louis LeBrun remains XNA’s technical manager, and the team has been strengthened with the addition of Chris Shea, as sales & marketing director, and Todd Broad, as process engineer. LeBrun has been with X-Flow since its introduction to the US market three years ago. Shea has worked in membrane sales and business development in the water, wastewater and battery separation industries with WR Grace, USFilter and Koch. Broad has been an engineer with Illinois Water Treatment, a division of USFilter, for the past 14 years.
Editorial Office Elsevier Advanced Technology PO Box 150 Kidlington Oxford OX5 1AS United Kingdom Tel: +44 (0)1865 843695 Fax: +44 (0)1865 843971 E-mail: [email protected] Web: www.filtsep.com Editor Roisin Reidy Permissions may be sought directly from Elsevier Rights & Permissions Department, PO Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, e-mail: [email protected]. You may also contact Rights & Permissions directly through Elsevier’s home page (http://www.elsevier.com), selecting first ‘Customer Support’, then ‘General Information’, then Permissions Query Form’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: (978) 7508400, fax: (978) 7504744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: (+44) (0)20 7436 5931 ; fax: (+44) (0)20 7631 5500. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the publisher is required for resale or distribution outside the institution. Permission of the publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Contact the publisher at the address indicated. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the publisher. Address permissions requests to: Elsevier Rights & Permissions Department, at the mail, fax and e-mail addresses noted above. Notice No responsibility is assumed by the publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
02207 Printed by Mayfield Press (Oxford) Limited, UK.